Alembic Pharmaceuticals reports 38% surge in Q3 net profit

22 Jan 2014 Evaluate

Alembic Pharmaceuticals has reported results for third quarter ended December 31, 2013.

The company has reported 38.44% rise in its net profit at Rs 67.84 crore for the quarter as compared to Rs 49 crore for the same quarter in the previous year. Total income from operations of the company has increased by 29.07% at Rs 476.60 crore for quarter under review as compared to Rs 369.24 crore for the quarter ended December 31, 2012.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.

Alembic Pharma Share Price

899.90 -2.30 (-0.25%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×